-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

503. Hematopoiesis: Epigenetic, Transcriptional and Translational Control: Poster III

Hematopoiesis: Epigenetic, Transcriptional and Translational Control Program: Oral and Poster Abstracts
Type: Poster
Monday, December 7, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Tatsuya Morishima, MD, PhD1*, Regine Bernhard1*, Azadeh Zahabi1*, Benjamin Dannenmann1*, Masoud Nasri, M.Sc1*, Bardia Samareh, PhD1*, Lothar Kanz, Prof. Dr. med.2, Karl Welte, MD3* and Julia Skokowa, Prof. Dr.1*

1Division of Translational Oncology, Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University Hospital Tuebingen, Tuebingen, Germany
2Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University Hospital Tuebingen, Tuebingen, Germany
3University Children’s Hospital Tuebingen, Tuebingen, Germany

Minshi Wang1*, Yong Zhang1*, Shuyun Rao, Ph.D.2*, Jennifer Rhodes, PhD3* and Michele Rhodes1*

1Fox Chase Cancer Center, Philadelphia, PA
2Fox Chase Cancer Center, Temple Univeristy, Philadelphia, PA
3Basic Science Department, Fox Chase Cancer Center, Philadelphia, PA

Elisabeth F. Heuston, PhD1*, Cheryl A. Keller, PhD2*, Stacie M. Anderson1*, NIH Intramural Sequencing Center3*, Ross C. Hardison, PhD2* and David M. Bodine, PhD1

1NHGRI, Bethesda, MD
2Penn State University, State College, PA
3NHGRI, Rockville, MD

Jeffrey Malik, PhD1*, Michael Getman, MS2*, Jacquelyn Lillis, MS3*, Patrick G. Gallagher, MD4 and Laurie A Steiner, MD5

1University of Rochester Medical Center, Rochester, NY
2University of Rochester, Rochester
3University of Rochester, Rochester, NY
4Department of Pediatrics, Yale School of Medicine, New Haven, CT
5Pediatrics, University of Rochester, Rochester, NY

Amanda Scholl, BS, Alexander Muselman, BS* and Dong-Er Zhang, PhD

University of California, San Diego, La Jolla, CA

Stephan Emmrich, PhD1*, Sarva Keihani, Msc1*, Dirk Reinhardt, MD2 and Jan-Henning Klusmann, MD3

1Pediatric Hematology & Oncology, Hanover Medical School, Hanover, Germany
2AML-BFM Study Group, Pediatric Hematology/Oncology, University Children’s Hospital Essen, Essen, Germany
3Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany

Atsushi Sato, MD1*, Hideyo Hirai, MD, PhD1, Asumi Yokota, PhD1*, Akihiro Tamura, MD1*, Tsukimi Shoji1*, Takahiro Kashiwagi1*, Masaki Iwasa, MD1,2*, Aya Fujishiro, MD1,2*, Yasuo Miura, MD, PhD1 and Taira Maekawa, MD, PhD1

1Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital, Kyoto, Japan
2Division of Gastroenterology and Hematology, Shiga University of Medical Science, Shiga, Japan

Craig M Forester, MD, PhD1, Zhen Shi, PhD2*, Maria Barna, PhD2* and Davide Ruggero, PhD3*

1Helen Diller Cancer Center; Benioff Children's Hospital; Department of Pediatrics, University of California - San Francisco, San Francisco, CA
2Dept of Developmental Biology, Dept of Genetics, Stanford University, Palo Alto, CA
3Department of Urology, University of California San Francisco, San Francisco, CA

Adriana De La Garza-Sauceda*, Rosannah C. Cameron, Ph.D.*, Sara Nik*, Michelle Gulfo*, Sara G. Payne* and Teresa V. Bowman, Ph.D.

Department of Developmental and Molecular Biology, Department of Medicine (Oncology) and Gottesman Institute for Stem Cell Biology and Regenerative Medicine, Albert Einstein College of Medicine, Bronx, NY

Muluken S Belew, MS*, Stefan Rentas, MS*, Laura de Rooij, MS* and Kristin J Hope, PhD*

Stem Cell and Cancer Research Institute, McMaster University, Hamilton, ON, Canada

Atsushi Hasegawa, PhD1*, Hiroshi Kaneko, PhD1*, Daishi Ishihara1*, Masahiro Nakamura, MD, PhD2*, Akira Watanabe, PhD2*, Cecelia D Trainor, PhD3*, Yamamoto Masayuki, MD, PhD4,5* and Ritsuko Shimizu, MD, PhD1

1Department of Molecular Hematology, Tohoku University Graduate School of Medicine, Sendai, Japan
2Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan
3Laboratory of Molecular Biology, National Institutes of Health, Bethesda
4Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan
5Medical Mega-Bank Organization, Tohoku University, Sendai, Japan

Mathew G. Angelos, BS*, Anna Kim* and Dan S. Kaufman, M.D., Ph.D.

Department of Medicine and Stem Cell Institute, University of Minnesota, Minneapolis, MN

Ada Congrains, PhD*, João Agostinho Machado-Neto, MSc*, Flávia Adolfo Corrocher, MSc*, Renata Giardini Rosa, PhD*, Fernanda Soares Niemann, MSc* and Sara Teresinha Olalla Saad, PhD, MD

Hematology and Hemotherapy Center-University of Campinas/Hemocentro-Unicamp, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, Brazil

*signifies non-member of ASH